Last10K.com

Receptos, Inc. (RCPT) SEC Filing 10-K Annual report for the fiscal year ending Wednesday, December 31, 2014

Receptos, Inc.

CIK: 1463729 Ticker: RCPT
Document and Entity Information (USD $)
12 Months Ended
Dec. 31, 2014
Feb. 16, 2015
Jun. 30, 2014
Document And Entity Information [Abstract]      
Document Type 10-K    
Amendment Flag false    
Document Period End Date Dec. 31, 2014    
Document Fiscal Year Focus 2014    
Document Fiscal Period Focus FY    
Trading Symbol RCPT    
Entity Registrant Name Receptos, Inc.    
Entity Central Index Key 0001463729    
Current Fiscal Year End Date --12-31    
Entity Well-known Seasoned Issuer Yes    
Entity Current Reporting Status Yes    
Entity Voluntary Filers No    
Entity Filer Category Large Accelerated Filer    
Entity Common Stock, Shares Outstanding   31,545,073dei_EntityCommonStockSharesOutstanding  
Entity Public Float     $ 922,734,616dei_EntityPublicFloat

View differences made from one year to another to evaluate Receptos, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Receptos, Inc..

Continue

Assess how Receptos, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Receptos, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2015 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 10-K Annual Report

Document And Entity Information
Consolidated Balance Sheets
Consolidated Balance Sheets (parenthetical)
Consolidated Statements Of Cash Flows
Consolidated Statements Of Convertible Preferred Stock And Stockholders' Equity (deficit)
Consolidated Statements Of Operations And Comprehensive Loss
Balance Sheet Details
Balance Sheet Details (tables)
Balance Sheet Details - Summary Of Major Classes Of Accrued Expenses (detail)
Balance Sheet Details - Summary Of Major Classes Of Prepaid Expenses And Other Current Assets (detail)
Balance Sheet Details - Summary Of Major Classes Of Property And Equipment (detail)
Collaborative Arrangements
Collaborative Arrangements - Additional Information (detail)
Commitments And Contingencies
Commitments And Contingencies (tables)
Commitments And Contingencies - Additional Information (detail)
Commitments And Contingencies - Additional Information 1 (detail)
Commitments And Contingencies - Schedule Of Future Minimum Lease Payments Due Under Facility Leases (detail)
Description Of Business
Description Of Business - Additional Information (detail)
Employee Benefits
Employee Benefits - Additional Information (detail)
Fair Value Measurements
Fair Value Measurements (tables)
Fair Value Measurements - Additional Information (detail)
Fair Value Measurements - Summary Of Fair Value Of The Company's Investment Holdings (detail)
Income Taxes
Income Taxes (tables)
Income Taxes - Additional Information (detail)
Income Taxes - Schedule Of Reconciliation Of Expected Statutory Federal Income Tax Provision To Actual Income Tax Provision (detail)
Income Taxes - Summary Of Significant Components Of Deferred Tax Assets (detail)
Selected Quarterly Financial Information
Selected Quarterly Financial Information (tables)
Selected Quarterly Financial Information - Summary Of Selected Quarterly Financial Data (detail)
Short-term Investments
Short-term Investments (tables)
Short-term Investments - Additional Information (detail)
Short-term Investments - Schedule Of Carrying Value Of Available For Sale Securities Classified As Short-term Investments (detail)
Short-term Investments - Summary Of Company's Short-term Investments In Unrealized Loss Position (detail)
Short-term Investments - Summary Of Contract Maturity Of Available For Sale Securities (detail)
Stock-based Compensation And Equity Plans
Stock-based Compensation And Equity Plans (tables)
Stock-based Compensation And Equity Plans - Additional Information (detail)
Stock-based Compensation And Equity Plans - Schedule Of Weighted-average Assumptions Underlying Calculation Of Grant Date Fair Value (detail)
Stock-based Compensation And Equity Plans - Summary Of Share-based Compensation Expense For All Equity Awards Granted (detail)
Stock-based Compensation And Equity Plans - Summary Of Stock Option Activity (detail)
Stock-based Compensation And Equity Plans - Summary Of Stock Option Activity (parenthetical) (detail)
Stockholders' Equity
Stockholders' Equity - Additional Information (detail)
Subsequent Events
Subsequent Events - Additional Information (detail)
Summary Of Significant Accounting Policies
Summary Of Significant Accounting Policies (policies)
Summary Of Significant Accounting Policies - Additional Information (detail)
Term Loan And Security Agreement
Term Loan And Security Agreement - Additional Information (detail)
Ticker: RCPT
CIK: 1463729
Form Type: 10-K Annual Report
Accession Number: 0001193125-15-071752
Submitted to the SEC: Mon Mar 02 2015 7:54:00 AM EST
Accepted by the SEC: Mon Mar 02 2015
Period: Wednesday, December 31, 2014
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/rcpt/0001193125-15-071752.htm